Healthcare Pharmaceutical Biotech

Cannabis Industry Attorney Concedes D.C. Circuit Challenge Could Reverse Marijuana Rescheduling

June 16, 2026 6:00 AM

MMJ International Holdings today highlighted a significant development in the ongoing legal challenge to the federal government's marijuana rescheduling order after cannabis industry attorney Jason Adelstone publicly acknowledged that the D.C. Circuit challenge brought by MMJ International Holdings and the National Drug and Alcohol Screening Association (NDASA) presents a substantial threat to the Schedule III rule. In a June 15 analysis...

Read more

Positive Results From The Phase Ib Clinical Study of NeuroRestore ACD856, Under Development for Alzheimer's

June 16, 2026 4:45 AM

AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the Phase Ib clinical study of ACD856, the lead drug candidate in the NeuroRestore platform being developed for Alzheimer's disease and other indications, has been completed on schedule with positive results. "Consistent with previous clinical...

Read more

Teknova Expands Digital Publication Experience with Bioz Content Hub Integration

June 16, 2026 4:00 AM

Bioz, Inc., an innovative platform focused on extracting and syndicating insights from scientific publications, announced its continued collaboration with Teknova, a leading manufacturer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Building on a long-standing collaboration, Teknova has expanded its use of Bioz Badges by implementing a fully customized Bioz...

Read more

IRLAB Presents Integrated Analysis of Mesdopetam Data at International Conference - Confirms Robust Efficacy Results in the Phase II Studies

June 16, 2026 1:15 AM

IRLAB Therapeutics AB ((STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announces that an integrated analysis of clinical data for mesdopetam, IRLAB's most advanced drug candidate in development to treat levodopa-induced dyskinesia, will be presented at StanCon 2026 in Uppsala in August. The analysis confirms mesdopetam's anti-dyskinetic effect across a broad range of statistical...

Read more

Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2026

June 15, 2026 5:00 PM

Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm today announced that revenues for the three and six months ended April 30, 2026 were approximately $2.7 million and $5.0 million, respectively, representing increases of approximately $0.3 million and $0.1 million compared to the same periods last year. Net income for the three and six months...

Read more

"Three Women and Me" Launches a Bold New Health Media Platform Designed to Change the Conversation Around Women's Health and the Issues Families Face Every Day

June 15, 2026 2:45 PM

At a time when millions of women are searching for answers, navigating complex health challenges, and often feeling unheard, a groundbreaking new television talk show and podcast is preparing to transform the way health conversations happen. Three Women and Me is not just another talk show. It is a bold new media platform created to tackle the questions that affect women, families, relationships, and communities every day, but are too often...

Read more

Harvard Neuroscientist Warns Federal Court: Marijuana Rescheduling May Carry "Unacceptably High" Public Health Risks

June 15, 2026 11:00 AM

As the U.S. Court of Appeals for the D.C. Circuit weighs an emergency motion to stay the federal government's recent marijuana rescheduling order, a newly filed declaration from a Harvard Medical School professor warns that the policy change poses "substantial" and "unacceptably high" risks to public health-particularly for adolescents and unborn children. The declaration (Exhibit D), filed June 9 by Bertha K. Madras, Ph.D. , a Professor of...

Read more

Aetna Reduces Claims Processing Time by More Than 20% With AI To Improve Care Experience

June 15, 2026 9:00 AM

CVS Health Originally published on CVS Health Company Newsroom Aetna®, a CVS Health® company (NYSE:CVS), today announced the launch of the second generation Aetna Claims Assist Manager (CAM), an AI-powered agentic claims advisor platform designed to streamline claims processing and improve payment accuracy. Insurance claims processing remains a major cost driver across the U.S. healthcare system, where administrative activities account for...

Read more

Becker Aesthetics & Plastic Surgery Shares Insights on Male Rhinoplasty Trends in Philadelphia

June 15, 2026 9:00 AM

Rhinoplasty has become one of the most requested procedures among men, and the thinking behind it is changing. At Becker Aesthetics & Plastic Surgery, which serves patients in Philadelphia and throughout the surrounding region, the facial plastic surgery team is seeing more male patients ask for results that look refined rather than obviously altered. For many, the goal is to look more like themselves, whether that means appearing more rested in...

Read more

MedSyntra Announces MedSyntra Healthcare Data Readiness Index TM and Releases 2026 Healthcare Data Readiness Framework

June 15, 2026 9:00 AM

MedSyntra today announced the launch of the MedSyntra Healthcare Data Readiness Index™, a new initiative designed to assess and benchmark healthcare organizations, healthcare systems, and national healthcare infrastructures on their preparedness for artificial intelligence, precision medicine, and data-driven healthcare innovation. Alongside the announcement, the company released its 2026 Healthcare Data Readiness Framework, providing healthcare...

Read more

As the Ebola Epidemic Spreads, NV-387 Oral Gummies Can Enter a Phase II Clinical Trial for Treatment of Ebola - NanoViricides Proposal is Approved by the Pillar Committee in DR Congo

June 15, 2026 8:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, NanoViricides announces that its proposal to perform a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for the Current Bundibugyo Ebolavirus has been approved by the Pillar Committee in Charge in the Democratic Republic of Congo (DRC). There is no approved treatment or vaccine for the new variant...

Read more

Kobe Bryant's Series-Clinching NBA Finals Sneakers Could Become One of the Most Watched Sports Memorabilia Auctions of the Year

June 15, 2026 8:01 AM

Infinite Auctions is a wholly owned subsidiary of Medical Care Technologies, Inc. (OTC PINK:MDCE) has announced the upcoming offering of one of the most significant Kobe Bryant game-worn artifacts to reach the public marketplace in recent years: Kobe Bryant's game-worn and dual-signed Adidas "The Kobe 1" sneakers worn during Game 5 of the 2001 NBA Finals, photo-matched to the Los Angeles Lakers' championship-clinching victory over the...

Read more

Telomir Pharmaceuticals Announces Peer-Reviewed Publication in Biomedicine & Pharmacotherapy Demonstrating Restoration of Insulin Sensitivity with Telomir-Zn in a Preclinical Type 2 Diabetes Model

June 15, 2026 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a clinical-stage biotechnology company developing small-molecule therapeutics targeting epigenetic and metabolic drivers of cancer and age-related disease, today announced the peer-reviewed publication of preclinical data demonstrating restoration of insulin sensitivity and significant improvement in glucose homeostasis with Telomir-Zn in a diet-induced zebrafish model of...

Read more

Fine Treatment Highlights Rising Interest in Non-Invasive Therapies for Benign Prostatic Hyperplasia

June 15, 2026 7:45 AM

Fine Treatment has highlighted increasing interest in non-invasive therapeutic approaches for the management of benign prostatic hyperplasia (BPH), a common age-related condition affecting millions of men worldwide. Growing awareness of treatment safety, quality-of-life considerations, and long-term symptom management continues to influence discussions surrounding enlarged prostate care. Benign prostatic hyperplasia is a non-cancerous...

Read more

Cotiviti Leads 2026 Black Book Payer Claims Platform Rankings, Rated #1 by Managed Care Clients

June 15, 2026 7:30 AM

Cotiviti earned the #1 client-rated position in payer claims platform performance in Black Book Research's 2026 State of Payer Digital Technology: Managed Care and Health Plans survey, as managed care organizations prepare for a more selective 2027 buying cycle focused on claims precision, payment-policy governance, transparency, provider trust and administrative cost control. In Black Book Research's 2026 State of Payer Digital Technology:...

Read more

BioNxt Engages Business Development & Licensing Advisors for Commercialization of Patented Sublingual Cladribine ODF

June 15, 2026 3:45 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that it has commenced work with a Business Development & Licensing ("BD&L") specialist advisor to support the commercialization and partnering strategy for BNT23001, the Company's patented proprietary sublingual Cladribine orally dissolvable film ("ODF") formulation for...

Read more

Eight New Jersey Complete Care Centers Earn National Quality Award for Commitment to Quality Care

June 14, 2026 10:00 AM

Complete Care is proud to announce that eight of its New Jersey skilled nursing and rehabilitation centers have been recognized as recipients of the 2026 Bronze - Commitment to Quality Award by the American Health Care Association and National Center for Assisted Living (AHCA/NCAL). The following New Jersey Complete Care centers earned the national distinction: Complete Care at Cedar Grove Complete Care at Harborage Complete Care at Park Place...

Read more

Complete Care at Southpointe Earns National Quality Award for Commitment to Quality Care

June 14, 2026 10:00 AM

Complete Care is proud to announce that Southpointe has been recognized as a recipient of the 2026 Bronze - Commitment to Quality Award by the American Health Care Association and National Center for Assisted Living (AHCA/NCAL). The national distinction recognizes long-term and post-acute care providers that demonstrate a commitment to enhancing quality care and improving the lives of the residents they serve. The Bronze Award is the first of...

Read more

Two Connecticut Complete Care Centers Earn National Quality Award

June 14, 2026 10:00 AM

Complete Care is proud to announce that Kimberly Hall North and Glendale have been recognized as recipients of the 2026 Bronze - Commitment to Quality Award by the American Health Care Association and National Center for Assisted Living (AHCA/NCAL). The national distinction recognizes long-term and post-acute care providers that demonstrate a commitment to enhancing quality care and improving the lives of the residents they serve. The Bronze...

Read more

Three Mid-Atlantic Complete Care Centers Earn National Quality Award

June 14, 2026 10:00 AM

Complete Care is proud to announce that Dawnview, Silver Lake and Brackenville have been recognized as recipients of the 2026 Bronze - Commitment to Quality Award by the American Health Care Association and National Center for Assisted Living (AHCA/NCAL). The national distinction recognizes long-term and post-acute care providers that demonstrate a commitment to enhancing quality care and improving the lives of the residents they serve. The...

Read more